èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Lipocine Inc. ã¯ã代è¬ããã³å
åæ³éå®³ã®æ²»çã®ããã®å»è¬åã®éçºã«éç¹ã眮ããŠããŸããå瀟ã®äž»ãªéçºããã°ã©ã ã¯ãçç©åŠçå©çšèœãäœãè¬ç©ã®çµå£æäžãœãªã¥ãŒã·ã§ã³ã«åºã¥ããŠããŸããå瀟ã¯ãè¬ç©åæ
ç¹æ§ãçã¿åºããæäžèŠä»¶ã®äœæžãä¿é²ããç¹å®ã®ã±ãŒã¹ã§ååéé代è¬ãåé¿ããå¯äœçšã軜æžããçç©åŠçå©çšèœãå¶éããèè
žçžäºäœçšãæé€ããããã«èšèšããã補ååè£ã®ããŒããã©ãªãªãæã£ãŠããŸãããã®äž»å補ååè£ã¯ãçµå£ãã¹ãã¹ããã³è£å
çæ³ã§ãã TLANDO ã§ããå瀟ã®ãã€ãã©ã€ã³åè£ã«ã¯ãéè硬å€éã¢ã«ã³ãŒã«æ§èèªèç (NASH) ã®æ²»çã®ããã®ç¬¬ II çžèšåºè©Šéšäžã®ãã€ãªã¢ã€ãã³ãã£ã«ã« ãã¹ãã¹ããã³ã®çµå£ãããã©ãã°ã§ãã LPCN 1144ãæ§è
ºæ©èœäœäžçã®ç·æ§ã察象ã«ç¬¬ II çžèšåºè©Šéšãå®äºããã1 æ¥ 1 åæäžã®ãã¹ãã¹ããã³ã®çµå£ãããã©ãã°ã§ãã TLANDO XR ããããŸãã LPCN 1148 ã¯ãNASH è硬å€ã®æ²»çãç®çãšãã第 I çžèšåºè©Šéšãå®äºãããã€ãªã¢ã€ãã³ãã£ã«ã« ãã¹ãã¹ããã³ã®çµå£ãããã©ãã°ã§ããLPCN 1107 ã¯ãåçºæ§æ©ç£ã®äºé²ãç®çãšããçšéèšå®ã®ç¬¬ II çžèšåºè©Šéšãå®äºããçµå£ããããã·ããã²ã¹ããã³ ã«ããã³é
žè£œåã§ããåç€Ÿã®æ¬ç€Ÿã¯ãŠã¿å·ãœã«ãã¬ã€ã¯ã·ãã£ã«ãããŸãã